What is the treatment for bronchospasm in a moderate allergic reaction?

The treatment for bronchospasm in a moderate allergic reaction is to administer albuterol, which is a bronchodilator. Administering albuterol via nebulizer at a dose of 2.5 mg is effective in relaxing the muscles around the airways, leading to dilation and improved airflow. This is particularly important in the context of an allergic reaction, where bronchospasm can significantly compromise a patient's breathing.

The ability to repeat the albuterol treatment as needed (prn) allows for flexibility in managing the patient's symptoms effectively, especially if their respiratory distress persists or worsens. This option is focused specifically on alleviating the immediate symptoms of bronchospasm, making it an appropriate choice for someone experiencing this complication during a moderate allergic reaction.